In this episode, Dr. Kate Dee and Dr. Randy Lindstrom discuss weight loss medications, particularly focusing on the benefits and differences between Semaglutide (Ozempic/Wegovy) and Tirzepatide (Manjaro/ZepBound). They explain the scientific mechanisms, potential side effects, and legal issues surrounding these treatments. Both doctors share their personal experiences using these drugs and highlight the importance of medical guidance when undergoing such treatments. They also introduce their new weight loss program, GlowFit, and its structured approach to helping patients achieve their weight loss goals safely and effectively.
Check out the Medspa Mayhem website for
-
More about Dr. Dee
-
Upcoming appearances
-
Links to buy the book on Bookshop, B&N, Amazon
-
Press and Podcast info
Glow Medispa in Seattle, WA
Purchase Medspa Mayhem on Amazon
Find out more about GlowFit Tirzepatide program
Takeaways
-
Tirzepatide is a weight loss medication that decreases appetite and slows emptying of the stomach
-
Medical management is crucial for safe and effective weight loss.
-
Personal experiences with Tirzepatide show significant weight loss with few side effects.
-
The Glowfit program aims to provide comprehensive support for weight loss.
-
Education about the medication and its effects is essential for users.
-
Tirzepatide has a lower side effect profile compared to semaglutide.
-
The future of weight loss medications is promising with ongoing research.
-
Maintaining muscle mass is important during weight loss.
-
The program is designed to cater to a wide range of weight loss goals.
Chapters
00:00 Food Chatter and Its Impact
01:24 Meet Dr. Randy Lindstrom
02:12 Excitement About Tirzapatide
04:04 Understanding Ozempic and Its Side Effects
08:37 All about Tirzapatide
13:01 Launching the Glow Fit Program
17:06 Sourcing and Legality of Weight Loss Drugs
23:27 Personal Experiences with Terzapatide
32:41 Conclusion and Future Plans
資訊
- 節目
- 頻率每週更新
- 發佈時間2024年10月2日 上午10:00 [UTC]
- 長度34 分鐘
- 季數2
- 集數8
- 年齡分級兒少適宜